Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Roles for negative cell regulator 14-3-3σ in control of MDM2 activities

Abstract

The 14-3-3σ, upregulated by p53 in response to DNA damage, can have a positive-feedback impact driving p53 activities and is a human cancer epithelial marker downregulated in various tumors. However, the precise roles of 14-3-3σ during tumorigenesis are not well characterized. Here, we show that 14-3-3σ is a critical regulator of murine double minute oncogene (MDM2). 14-3-3σ interacts with MDM2 at the RING domain. The C-terminal region of 14-3-3σ binds to MDM2 very efficiently. Importantly, 14-3-3σ overexpression leads to destabilization of MDM2 through enhancing MDM2 self-ubiquitination and accelerating turnover rate. Conversely, loss of 14-3-3σ results in a significant increase in MDM2 protein. Moreover, live-cell images indicated that 14-3-3σ can affect the location of MDM2 from the nucleus to the cytoplasm, and that MDM2-mediated cytoplasmic localization of p53 can be reversed by the presence of 14-3-3σ. Significantly, we further showed that 14-3-3σ causes MDM2 downregulation, thereby stabilizing p53 and inhibiting tumor growth in animal tumors. Also, 14-3-3σ blocks MDM2-mediated retinoblastoma degradation and p53 NEDDylation. Our results provide evidence that 14-3-3σ is a pivotal MDM2 regulator involved in blocking a variety of activities of MDM2.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 7
Figure 3
Figure 4
Figure 5
Figure 6

Similar content being viewed by others

References

  • Chan TA, Hermeking H, Lengauer C, Kinzler KW, Vogelstein B . (1999). 14-3-3Sigma is required to prevent mitotic catastrophe after DNA damage. Nature 401: 616–620.

    Article  CAS  Google Scholar 

  • Fang S, Jensen JP, Ludwig RL, Vousden KH, Weissman AM . (2000). Mdm2 is a RING finger-dependent ubiquitin protein ligase for itself and p53. J Biol Chem 275: 8945–8951.

    Article  CAS  Google Scholar 

  • Ferguson AT, Evron E, Umbricht CB, Pandita TK, Chan TA, Hermeking H et al. (2000). High frequency of hypermethylation at the 14-3-3 sigma locus leads to gene silencing in breast cancer. Proc Natl Acad Sci USA 97: 6049–6054.

    Article  CAS  Google Scholar 

  • Fu H, Subramanian RR, Masters SC . (2000). 14-3-3 proteins: structure, function, and regulation. Annu Rev Pharmacol Toxicol 40: 617–647.

    Article  CAS  Google Scholar 

  • Geyer RK, Yu ZK, Maki CG . (2000). The MDM2 RING-finger domain is required to promote p53 nuclear export. Nat Cell Biol 2: 569–573.

    Article  CAS  Google Scholar 

  • He TC, Zhou S, da Costa LT, Yu J, Kinzler KW, Vogelstein B . (1998). A simplified system for generating recombinant adenoviruses. Proc Natl Acad Sci USA 95: 2509–2514.

    Article  CAS  Google Scholar 

  • Hermeking H, Lengauer C, Polyak K, He TC, Zhang L, Thiagalingam S et al. (1997). 14-3-3 sigma is a p53-regulated inhibitor of G2/M progression. Mol Cell 1: 3–11.

    Article  CAS  Google Scholar 

  • Iwakuma T, Lozano G . (2003). MDM2, an introduction. Mol Cancer Res 1: 993–1000.

    CAS  PubMed  Google Scholar 

  • Laronga C, Yang HY, Neal C, Lee MH . (2000). Association of the cyclin-dependent kinases and 14-3-3 sigma negatively regulates cell cycle progression. J Biol Chem 275: 23106–23112.

    Article  CAS  Google Scholar 

  • Lee MH, Lozano G . (2006). Regulation of the p53-MDM2 pathway by 14-3-3 sigma and other proteins. Semin Cancer Biol 16: 225–234.

    Article  CAS  Google Scholar 

  • Lee MH, Reynisdottir I, Massague J . (1995). Cloning of p57KIP2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution. Genes Dev 9: 639–649.

    Article  CAS  Google Scholar 

  • Miwa S, Uchida C, Kitagawa K, Hattori T, Oda T, Sugimura H et al. (2006). Mdm2-mediated pRB downregulation is involved in carcinogenesis in a p53-independent manner. Biochem Biophys Res Commun 340: 54–61.

    Article  CAS  Google Scholar 

  • Momand J, Jung D, Wilczynski S, Niland J . (1998). The MDM2 gene amplification database. Nucleic Acids Res 26: 3453–3459.

    Article  CAS  Google Scholar 

  • Oliner JD, Kinzler KW, Meltzer PS, George DL, Vogelstein B . (1992). Amplification of a gene encoding a p53-associated protein in human sarcomas. Nature 358: 80–83.

    Article  CAS  Google Scholar 

  • Sdek P, Ying H, Chang DL, Qiu W, Zheng H, Touitou R et al. (2005). MDM2 promotes proteasome-dependent ubiquitin-independent degradation of retinoblastoma protein. Mol Cell 20: 699–708.

    Article  CAS  Google Scholar 

  • Stommel JM, Marchenko ND, Jimenez GS, Moll UM, Hope TJ, Wahl GM . (1999). A leucine-rich nuclear export signal in the p53 tetramerization domain: regulation of subcellular localization and p53 activity by NES masking. EMBO J 18: 1660–1672.

    Article  CAS  Google Scholar 

  • Wang C, Ivanov A, Chen L, Fredericks WJ, Seto E, Rauscher III FJ et al. (2005). MDM2 interaction with nuclear corepressor KAP1 contributes to p53 inactivation. EMBO J 24: 3279–3290.

    Article  CAS  Google Scholar 

  • Xirodimas DP, Saville MK, Bourdon JC, Hay RT, Lane DP . (2004). Mdm2-mediated NEDD8 conjugation of p53 inhibits its transcriptional activity. Cell 118: 83–97.

    Article  CAS  Google Scholar 

  • Yang H, Wen YY, Zhao R, Lin YL, Fournier K, Yang HY et al. (2006). DNA damage-induced protein 14-3-3 {sigma} inhibits protein kinase B/Akt activation and suppresses Akt-activated cancer. Cancer Res 66: 3096–3105.

    Article  CAS  Google Scholar 

  • Yang HY, Wen YY, Chen CH, Lozano G, Lee MH . (2003). 14-3-3 sigma positively regulates p53 and suppresses tumor growth. Mol Cell Biol 23: 7096–7107.

    Article  CAS  Google Scholar 

  • Yu J, Zhang L, Hwang PM, Kinzler KW, Vogelstein B . (2001). PUMA induces the rapid apoptosis of colorectal cancer cells. Mol Cell 7: 673–682.

    Article  CAS  Google Scholar 

  • Zhang R, Wang H . (2000). MDM2 oncogene as a novel target for human cancer therapy. Curr Pharm Des 6: 393–416.

    Article  CAS  Google Scholar 

  • Zhou BP, Liao Y, Xia W, Zou Y, Spohn B, Hung MC . (2001). HER-2/neu induces p53 ubiquitination via Akt-mediated MDM2 phosphorylation. Nat Cell Biol 3: 973–982.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank Drs Vogelstein, Zhang, Kamitani, Shenoy, Wahl and Maki for valuable reagents, and Bill Spohn for live-cell imaging help. This work was supported in part by the NIHRO1CA (089266) and Cancer Center Core Grant (CA16672).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to M-H Lee.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yang, HY., Wen, YY., Lin, Yl. et al. Roles for negative cell regulator 14-3-3σ in control of MDM2 activities. Oncogene 26, 7355–7362 (2007). https://doi.org/10.1038/sj.onc.1210540

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1210540

Keywords

This article is cited by

Search

Quick links